Forgot?
3,4-Methylenedioxyamphetamine
Hallucinogens
Mescaline
N-Methyl-3,4-methylenedioxyamphetamine
Designer Drugs
Psilocybine
Psychoses, Substance-Induced
Substance-Related Disorders
Delirium, Dementia, Amnestic, Cognitive Disorders
Substance Withdrawal Syndrome
Neuropsychological Tests
Psychiatric Status Rating Scales
Magnetic Resonance Imaging
Double-Blind Method
Electroencephalography
Polysomnography
Single-Photon Emission-Computed Tomography
Brain
Dominance, Cerebral
Evoked Potentials
Co-Publications
12
11
9
7
5
4
3
2
1
Flash Player Required